ABOUT INDEXING EDITORIAL BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER NEWS, EVENTS AUTHOR'S PAGE CONTACT
Materiale Plastice
Cite as: Mater. Plast.
https://doi.org/10.37358/Mat.Plast.1964

OSIM Nr. R102356
ISSN Print 0025-5289
ISSN Online 2668-8220
Journal Metrics
* Impact factor 2019: 1.517
* 5-Year IF: 1.179
* CiteScore: 2.4
* H index: 22
Materiale Plastice - Latest Issue

Latest Issue >>>
ARCHIVES
   Volume 58, 2021
   Volume 57, 2020
   Volume 56, 2019
   Volume 55, 2018
   Volume 54, 2017
   Volume 53, 2016
   Volume 52, 2015
   Volume 51, 2014
   Volume 50, 2013
   Volume 49, 2012
   Volume 48, 2011
   Volume 47, 2010
   Volume 46, 2009
   Volume 45, 2008
   Volume 44, 2007
   Volume 43, 2006
   Volume 42, 2005
   Volume 41, 2004
   Volume 40, 2003
 
<<<< back

Materiale Plastice (Mater. Plast.), Year 2016, Volume 53, Issue 4, 787-790



Alina Calin, Isabela Loghin, Carmen Mihaela Dorobat, Cristian Budacu, Camelia Bogdanici

CDI Infection in Patients with Multiple Organ Dysfunction


Abstract:
Clostridium difficile infection (CDI) rates in the United States and the world have increased in the last decade, along with associated morbidity and mortality. CDI symptoms can range from mild diarrhea to severe cases including pseudomembranous colitis and toxic mega colon and death. We performed a retrospective study including 130 patients with multiple organ failure who developed Clostridium difficile infection, admitted to the Iasi Sf. Parascheva Infectious Diseases Hospital in the interval January 1st, 2014 - June 1st, 2016; in order to highlight the high incidence of it and showing how we can manage this situations. An increased number of patients with Clostridium difficile infection and multiple organ dysfunction, in 2015 and 2016 was noticed. The profile of the patient from our study is a female with the age over 65 years old, coming from the rural area. Many of the admitted cases were patients enrolled in Hemodialysis Center. Cardiovascular disease was the most common associated pathology (60.79%), followed by renal failure (42%). Charlson comorbidity index showed 3-4, for 97 cases. The specific antibiotherapy for CDI was administrated for 5-7 days to 21 days long. In 73% of the cases the CDI was treated, 17 cases recorded relapse, and one case died. Clostridium difficile is the most common enteric pathogen in hospitalized patients. Standardized procedures to implement hygienic measures and restricted use of antibiotics are necessary to control the widespread occurrence of CDI in immunocompromised renal patients.


Keywords:
Clostridium difficile infection; multiple organ dysfunction; Charlson comorbidity index; metronidazole; vancomycin

Issue: 2016 Volume 53, Issue 4
Pages: 787-790
Publication date: 2016/12/30
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
<<<< back
 
  Search Authors
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License